KIR diversity in three ethnic minority populations in China

[1] Ashouri E(2009)KIR gene content diversity in four Iranian populations Immunogenetics 61 483-492

[2] Farjadian S(2006)NK cells: new insights on physiology and clinical implication in diseases Rev Med Interne 27 465-472

[3] Reed EF(2011)HIV-1 adaptation to NK-cell-mediated immune pressure Nature 476 96-100

[4] Ghaderi A(2000)Plasticity in the organization and sequences of human KIR/ILT gene families Proc Natl Acad Sci USA 97 4778-4783

[5] Rajalingam R(2002)KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential J Immunol 168 6208-6214

[6] Schleinitz N(2005)MHC class Imolecules and KIRs in human history, health and survival Nat Rev Immunol 5 201-214

[7] Hamidou M(2007)Global diversity and evidence for coevolution of KIR and HLA Nat Genet 39 1114-1119

[8] Vély F(2007)Donor–recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation Hum Immunol 68 309-323

[9] Alter G(2013)KIR2DS4 allelic variants: differential effects on in utero and intrapartum HIV-1 mother-to-child transmission Clin Immunol 149 498-508

[10] Heckerman D(2007)Studies on the expression of the deleted KIR2DS4*003 gene product and distribution of KIR2DS4 deleted and nondeleted versions in different populations Hum Immunol 68 128-134

[1] Ashouri E(2009)KIR gene content diversity in four Iranian populations Immunogenetics 61 483-492

[2] Farjadian S(2006)NK cells: new insights on physiology and clinical implication in diseases Rev Med Interne 27 465-472

[3] Reed EF(2011)HIV-1 adaptation to NK-cell-mediated immune pressure Nature 476 96-100

[4] Ghaderi A(2000)Plasticity in the organization and sequences of human KIR/ILT gene families Proc Natl Acad Sci USA 97 4778-4783

[5] Rajalingam R(2002)KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential J Immunol 168 6208-6214

[6] Schleinitz N(2005)MHC class Imolecules and KIRs in human history, health and survival Nat Rev Immunol 5 201-214

[7] Hamidou M(2007)Global diversity and evidence for coevolution of KIR and HLA Nat Genet 39 1114-1119

[8] Vély F(2007)Donor–recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation Hum Immunol 68 309-323

[9] Alter G(2013)KIR2DS4 allelic variants: differential effects on in utero and intrapartum HIV-1 mother-to-child transmission Clin Immunol 149 498-508

[10] Heckerman D(2007)Studies on the expression of the deleted KIR2DS4*003 gene product and distribution of KIR2DS4 deleted and nondeleted versions in different populations Hum Immunol 68 128-134